Functional Impairment and Disability across Mood States in Bipolar Disorder  by Rosa, Adriane R. et al.
Functional Impairment and Disability across Mood States in
Bipolar Disordervhe_768 984..988
Adriane R. Rosa, PharmD, PhD,1 María Reinares, PsycD, PhD,1 Erin E. Michalak, MD, PhD,2
C. Mar Bonnin, PsycD,1 Brisa Sole, PsycD,1 Carolina Franco, MD,1 Mercè Comes, NurseD,1
Carla Torrent, PsycD, PhD,1 Flávio Kapczinski, MD, PhD,3 Eduard Vieta, MD, PhD1
1Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia,
Spain; 2Division of Mood Disorders, Department of Psychiatry, University of British Columbia,Vancouver, British Columbia, Canada; 3Bipolar
Disorder Program, Centro de Pesquisas, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
ABSTRACT
Background: Bipolar disorder (BD) represents a chronic and recurrent
illness that can lead to severe disruptions in family, social, and occupa-
tional functioning. The severity of mood symptomatology has been asso-
ciated with functional impairment in this population. However, the
majority of studies have assessed global functioning without considering
speciﬁc domains. The main objective of the current study was to assess
speciﬁc life domains of functioning as well as the overall functioning in
patients with BD across different mood states ([hypo] mania, depression,
or euthymia) compared with healthy controls by the means of a standard-
ized scale validated for BD.
Methods: The sample included 131 subjects with BD (68 in remission, 31
hypo [manic], and 32 depressed) and 61 healthy controls. The Functioning
Assessment Short Test was used to assess overall and multiple areas of
functional impairment (autonomy, occupational functioning, cognitive
functioning, interpersonal relationships, ﬁnancial issues, and leisure time).
Results: The results showed signiﬁcant intergroup differences; depressed
patients had the lowest functioning (48.03  12.38) followed by (hypo)
manic patients (39.81  13.99). The euthymic group showed least impair-
ment in functioning compared with the depression and (hypo) mania
groups (11.76  12.73) but still displayed signiﬁcant impairment when
compared with the healthy control group (5.93  4.43).
Conclusions: This study indicates that depressive symptoms are associ-
ated with greater negative impact on psychosocial functioning than (hypo)
manic symptoms. Further deﬁcits in functioning seem to persist during
remission. The results highlight the importance of aggressively treating
depression and mania and the need to develop psychosocial interventions
targeting to improve functional outcomes.
Keywords: bipolar disorder, functional impairment, functioning, mood
symptoms, outcome.
Introduction
Bipolar disorder (BD) represents a major public health concern;
the World Health Organization (WHO) ranks BD as the sixth
leading cause of years lost due to disability in young adults [1].
Individuals with BD incur higher health-care expenses, job
absenteeism, and short-term disability payments than controls
[2]. BD can also carry a heavy personal toll, often being associ-
ated with severe impairments in outcomes and quality of life
(QoL) [3–5].
Research into BD has been driven by the medical model; one
consequence of this orientation is that treatment outcomes in BD
have traditionally been assessed by the examination of clinical
information, such as rates of treatment response or remission as
measured by mania or depression symptom rating scales. More
recently, however, there has been increasing emphasis on the need
for additional measures to compliment symptomatic assess-
ments; for example, Keck [6] has suggested that “functional
outcomes are more meaningful measures of response to treat-
ment for BD than are scores on various psychiatric rating scales.”
Psychosocial functioning describes a person’s ability to perform
the daily life tasks and to engage in relationships with other
people in ways that are gratifying to the individual and to others
and that meet the needs of the community in which the person
lives. The assessment of psychosocial functioning should ideally
involve evaluation across one or more behavioral domains, such
as the individual’s ability to function socially or occupationally,
or to live independently, with functional recovery typically being
deﬁned as restoration of normal role functioning in the domains
under scrutiny [7,8]. It is now recognized that symptomatic and
functional outcomes in BD are not synonymous. For example, in
one oft-cited study of ﬁrst-episode patients, Tohen and colleagues
[9] reported that 98% of a sample of patients with BD achieved
syndromal recovery within 2 years compared with only 38%
achieving functional recovery (deﬁned as the proportion of
patients who regained occupational and living situations equiva-
lent to those they held before their episode).
Mood symptoms have been signiﬁcantly associated with
functional impairment in BD [10]. In general, symptoms of
depression have been found to account for more variance in
functioning than do symptoms of mania [11–13]. Using the
Longitudinal Interval Follow-up Evaluation assessment method,
data from a large follow-up study showed that increases in
depressive symptom severity in patients with BD are associated
with corresponding increases in psychosocial impairment [12].
Depressive symptoms have shown to be associated with func-
tional role impairment in multiple domains such as duties at
work or school, responsibilities at home, and relationships with
family and friends [14]. Some clinical variables and neurocogni-
tive impairments have also been related to poor psychosocial
functioning [15,16]. Despite this growing body of data, a paucity
of research investigating psychosocial functioning across mood
states in BD persists. In addition, existing studies have not always
used standardized scales for the assessment of functioning or
have used self-reported scales that some researchers argue may be
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confounded by mood state or personality traits [11,17]. Finally,
most previous research in this area has involved the assessment
of global psychosocial functioning as opposed to the assessment
of functioning within speciﬁc life domains. An understanding of
which speciﬁc domains of psychosocial functioning are mostly
impaired in patients with BD would be of clinical utility as such
information could contribute to the development of interventions
focused upon functional restoration.
There is a paucity of studies aiming to assess the functional
impairment in all phases of BD. The present study was conducted
to assess speciﬁc life domains of functioning as well as the overall
functioning in patients with BD across different mood states
([hypo] mania, depression, or euthymia) as compared with
healthy controls via the Functioning Assessment Short-Test
(FAST). We also evaluated the FAST sensitivity to detect minimal
differences in the severity of mood symptoms across the mood
states.
Methods
The study represents a cross-sectional analysis of the baseline
data collected for a longitudinal study of psychosocial function-
ing in patients with BD initiated in July 2007.
Subjects
The sample was recruited via the Bipolar Disorders Program of
the Hospital Clínic at the University of Barcelona (Spain). All
enrolled patients received pharmacological treatment by their
psychiatrist according to the program’s protocols in a naturalistic
manner. Inclusion criteria were age >18 years and fulﬁllment of
DSM-IV criteria for bipolar I or bipolar II disorder. The sample
was divided into three groups according to their scores on the
17-item Hamilton Depression Rating Scale (HAM-D) and the
Young Mania Rating Scale (YMRS). Participants with a HAM-D
score of 16 or greater were included in the depressive group (D).
Subjects with a YMRS score above 12 were included in the
(hypo) manic group (M). Subjects with a HAM-D score of 16 or
greater and a YMRS score of 20 or greater were considered to be
affected by a mixed state and were also included in the (hypo)
manic group. Subjects with HAM-D and YMRS scores below 7
were included in the euthymic group (E). Patients exhibiting
subsyndromal symptoms were excluded.
The healthy control group (C) included individuals with no
psychiatric or neurological history and no ﬁrst-degree family
members diagnosed with BD sampled from the regional general
population.
Sample Size
FAST scale, the objective variable aiming to evaluate the corre-
lation of functionality changes by episode (acute patients and
euthymic), was used to calculate the sample size. Our previous
data suggest a correlation between euthymic/controls with a
median of SD of 18.55  13.19 and 5.93  4.43, respectively.
In base of this data and considering a conﬁdence interval
(1-a) = 95% with a precision level of 0.05 for the FAST means
and assuming around 8% to 10% of dropouts among the study
patients, we needed to recruit approximately 22 patients for each
group.
Assessment
Both the Structured Clinical Interview for DSM-IV Axis I and
Axis II were administered to conﬁrm diagnosis [18,19]. Sociode-
mographic, clinical, and pharmacological data were collected via
a structured interview with the patient and examination of clini-
cal records. The 17-item HAM-D and the YMRS were adminis-
tered by trained raters to assess depressive and manic symptoms,
respectively [20,21]. The FAST (see appendix at: http://www.
ispor.org/Publications/value/ViHsupplementary/ViH13i8_Vieta.
asp) was utilized to assess functional impairment. It is a valid and
reliable instrument, easy to apply, and which requires a short
period of time to administer (3–6 min). It was developed for the
clinical evaluation of the main difﬁculties presented by psychiat-
ric patients and has been validated in several languages for
patients with BD [22]. The FAST scale consists of 24 items that
allow the assessment of six speciﬁc areas of functioning:
1. Autonomy refers to the patient’s capacity to do things alone
and make his or her own decisions.
2. Occupational functioning refers to the capacity to maintain
an employment, efﬁciency of performing tasks at work,
working in the ﬁeld in which the patient was educated, and
earning according to the level of the employment position.
3. Cognitive functioning is related to the ability to concen-
trate, perform simple mental calculations, solve problems,
and learn and recall new information.
4. Financial issues involve the capacity of managing the
ﬁnances and spending in a balanced way.
5. Interpersonal relationships refer to relations with friends
and family, involvement in social activities, sexual relation-
ships, and the ability to defend one’s own interests.
6. Leisure time refers to the capability of performing physical
activities (sport, exercise) and maintaining hobbies.
Items are rated using a 4-point scale where 0 = no difﬁculty,
1 = mild difﬁculty, 2 = moderate difﬁculty, and 3 = severe difﬁ-
culty. The overall FAST score ranges from 0 to 72, where higher
scores indicate greater disability, with a threshold score of 11
indicating the presence of signiﬁcant disability [22]. The FAST
was administered within the same day of the symptomatic assess-
ment by a trained rater who was blind to the participant’s group
allocation.
This study was approved by the Hospital Clínic of Barcelona
Ethics Committee. After receiving a complete verbal description
of the study, written informed consent was obtained from all the
participants.
Statistical Analysis
The statistical analysis was performed with the Statistical
Package for Social Sciences (SPSS v.16 for Windows, SPSS Inc,
Chicago, IL). The four groups (euthymic [hypo] manic,
depressed, and healthy control) were compared regarding clinical
and sociodemographic characteristics by using analysis of vari-
ance (ANOVA) and the chi-squared test, as appropriate. The
mean total scores and subscores of the FAST were compared
across the four groups using ANOVA, followed by the Tukey
post hoc comparison procedure when signiﬁcant main effects
were present. All P-values were two-tailed and statistical signiﬁ-
cance was set at P < 0.05.
Results
The sample comprised 68 euthymic BD patients, 31 in a hypo
(manic) episode, 32 in a depressive episode, and 61 healthy
controls. Demographic and clinical characteristics of the groups
of patients and healthy controls are shown in Table 1. The
patient groups showed signiﬁcant differences with regard to
severity of depressive symptoms (P = 0.001), severity of manic
symptoms (P = 0.001), number of hospitalizations (P = 0.010),
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and Axis II comorbidity (P = 0.002). Signiﬁcant differences were
also observed between groups regarding the use of mood stabi-
lizers and antidepressant agents (see Table 1).
Table 2 shows the total scores and subscores of the FAST
across the four groups. Patients with depression (hypo) mania
and euthymia experienced poorer overall functioning when com-
pared with the healthy control group (D: 48.03  12.38; M:
39.81  13.99; E: 11.76  12.73; C: 5.93  4.43; P < 0.001).
The depressive and (hypo) manic groups showed signiﬁcantly
poorer functioning compared with the euthymic and control
groups across all domains. Examination of between-group dif-
ferences illustrated that participants in the depressive group
showed more impairment than those in the (hypo) manic group
in autonomy (P < 0.001), cognitive functioning (P < 0.001),
interpersonal relationships (P < 0.001), leisure time (P < 0.001),
and overall functioning (P < 0.001). No statistically signiﬁcant
between-group differences were found in occupational function-
ing or ﬁnancial issues. When euthymic patients were compared
with the control group, ﬁndings were more favorable for the
latter in autonomy (P < 0.001), occupational functioning
(P < 0.001), cognitive functioning (P < 0.001), and interpersonal
relationships (P < 0.001).
Discussion
The main objective of this study was to examine functional
impairment across mood states in a well-characterized sample of
patients with BD and healthy controls via scale validated for use
in BD. The FAST is an interviewer-administered instrument that
permits exploration of speciﬁc domains of functioning and dis-
ability. Higher functional impairment was observed in patients
who were in a depressive episode, followed by patients in a hypo
(manic) episode, and ﬁnally the euthymic group. Compared with
the healthy control group, patients with BD in clinical remission
still showed poorer psychosocial functioning.
Our ﬁndings are consistent with previous cross-sectional and
longitudinal studies where the presence of mood episodes in BD
has been strongly associated with poor functioning [14,23,24].
Table 1 Clinical and demographic characteristics in patients and control group
Euthymic (E) (Hypo) Manic (M) Depressed (D) Control (C) ANOVA
PMean SD Mean SD Mean SD Mean SD F
Age 48.06 13.76 50.42 16.23 49.47 13.58 49.16 17.66 0.18 0.909
Age at onset of illness 26.92 10.40 29.64 15.46 27.76 10.96 0.47 0.623
HAM-D 1.55 2.10 8.10 8.11 20.29 4.68 162.95 0.001
YMRS 0.93 1.94 19.77 7.42 2.94 3.55 216.55 0.001
Number of hospitalizations 2.05 2.08 3.56 2.26 3.29 3.01 4.86 0.010
Number of depressive episodes 7.02 11.16 8.50 8.52 6.91 4.81 0.22 0.806
Number of hypomanic episodes 5.32 11.25 4.91 6.67 2.64 2.82 0.69 0.502
Number of manic episodes 3.11 4.68 4.79 4.23 5.00 5.89 1.76 0.177
Number of mixed episodes 0.59 1.03 1.32 2.44 1.00 1.16 2.17 0.120
Number of total episodes 15.68 21.64 19.82 16.83 15.83 10.85 0.41 0.664
Number of suicide attempts 0.56 1.15 0.56 0.82 0.95 1.16 1.08 0.343
N (%) N (%) N (%) N (%) X2 P
Male 34 (50.0) 15 (48.40) 11 (34.40) 26 (42.60) 2.43 0.488
University or postgraduate complete 23 (33.8) 9 (29.0) 12 (37.50) 15 (24.60) 2.12 0.548
Married 22 (33.8) 7 (26.90) 9 (36.0) 5.55 0.476
Bipolar type I 48 (72.7) 26 (92.90) 19 (76.0) 10.10 0.120
Lifetime history of psychotic symptoms 39 (60.9) 19 (79.20) 16 (69.60) 2.72 0.257
Family history of affective disorder 31 (52.50) 12 (48.0) 17 (68.0) 2.35 0.309
Lifetime substance abuse 43 (63.2) 24 (77.4) 18 (56.20) 3.27 0.195
Rapid cycling 7 (11.10) 7 (29.20) 5 (20.80) 4.29 0.117
Axis I comorbidity 29 (42.60) 18 (58.10) 17 (53.10) 2.33 0.311
Axis II comorbidity 21 (30.90) 17 (54.80) 21 (65.60) 12.19 0.002
Current medications
Mood stabilizer 59 (86.80) 22 (71.0) 21 (65.60) 6.76 0.034
Antipsychotics 38 (55.90) 21 (67.70) 14 (43.80) 3.67 0.159
Antidepressants 20 (29.4) 4 (12.90) 14 (43.80) 7.29 0.026
Benzodiazepines 33 (48.50) 17 (54.80) 16 (50.0) 0.34 0.843
HAM-D, Hamilton Depression Rating Scale;YMRS,Young Mania Rating Scale.
Table 2 Functional impairment across different domains in patient and control group
Euthymic (E) (Hypo)Manic (M) Depressed (D) Control (C)
ANOVA
P
Tukey post hoc
tests
N = 68 N = 31 N = 32 N = 61
Mean SD Mean SD Mean SD Mean SD F
FAST total 11.76 12.73 39.81 13.99 48.03 12.38 5.93 4.43 128.49 P < 0.001 D > M > E > C
FAST autonomy 2.19 2.88 6.10 3.62 8.00 3.26 0.38 0.99 72.64 P < 0.001 D > M > E > C
FAST occupational 6.13 6.44 12.45 4.92 12.81 4.44 1.16 2.09 58.78 P < 0.001 D = M > E > C
FAST cognitive 3.15 3.10 7.64 4.01 10.00 3.35 1.00 1.06 85.82 P < 0.001 D > M > E > C
FAST interpersonal relationships 3.88 3.14 8.07 4.20 11.22 4.12 1.82 2.56 66.02 P < 0.001 D > M > E > C
FAST ﬁnancial issues 0.51 1.26 2.00 2.20 1.34 1.79 0.18 0.53 14.09 P < 0.001 D = M > E = C
FAST leisure time 1.90 1.79 3.45 1.95 4.84 1.59 1.39 1.29 36.66 P < 0.001 D > M > E = C
FAST, Functioning Assessment Short-Test.
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Judd and colleagues [12] have reported that each increment in
depressive symptom severity for patients with BD I and II is
associated with a corresponding increase in psychosocial impair-
ment, with the strongest associations being observed between
functional impairment and symptoms of mania in patients with
BD type I. In other research, Simon and colleagues [11] observed
that patients with depression or mania exhibited greater impair-
ment than patients in remission, with symptoms of depression
being associated with greater disability than symptoms of mania.
Our results complement those of Simon and colleagues as we also
observed that depressive symptoms led to a greater functional
impairment than hypo (manic) symptoms, although patients with
(hypo) mania showed poorer functioning than remitted patients
and healthy controls. Other authors have also found a strong
relationship between the severity of depressive symptoms and the
level of functional impairment in this population [11,25,26].
Depression rather than mania may have a greater impact on
particular areas of functioning such as social and daily activities
[11], and work productivity measured as employment and days
missed from work [26]. Although in our study no differences
were found in occupational functioning between patients with
mania or depression, the latter showed fewer social interactions
with friends and family, less interest or pleasure in the leisure
activities, less autonomy to maintain duties, and worse cognitive
functioning. Bipolar depression may have an insidious onset;
however, the impact on life functioning is enduring. In compari-
son with the treatment of mania, which can often occur relatively
quickly [27], the treatment of depression can be associated with
longer times to recovery, with a chronic course holding the poten-
tial for greater deﬁcits in psychosocial functioning.
We also observed that euthymic patients with BD experienced
poorer psychosocial functioning than healthy controls. Our
results conﬁrm ﬁndings of previous studies that have suggested
that patients with BD suffer from substantial functional impair-
ment even in periods of remission [28–30]. Subsyndromal
depressive symptoms have been consistently associated with poor
psychosocial functioning [31–33]. In a recent study, we found
that residual depressive symptoms, albeit minimal (HAM-D < 7),
were strongly associated with occupational impairment and
cognitive impairment in euthymic patients [34]. It is worth men-
tioning that numerous studies have reported persistent neurop-
sychological deﬁcits not only in acute but also in euthymic
patients with BD [15]. Cognitive deﬁcits, especially verbal
memory and sustained attention, have also been associated with
poor psychosocial and occupational functioning [15,35]. Deﬁcits
in memory, attention, and planning may lead to impairment in
social, interpersonal, and occupational functioning, and these
deﬁcits make it difﬁcult to undertake occupational tasks or
engage in interpersonal relationships [30]. Furthermore, the
number of episodes an individual experiences, particularly
depressive episodes, seems to be a strong predictor of future
recurrence and poor psychosocial functioning [36]. It has been
suggested that recurrent episodes may contribute to persistent
brain changes and long-lasting biochemical changes; these
changes may exert an effect on functioning even during periods
of symptom quiescence [37,38]. Taken together, these data
suggest that prophylactic treatments in BD should be comple-
mented with the development of therapeutic interventions aimed
at improving functional outcomes. Together with syndromal
recovery, full functional recovery should be the goal of the treat-
ment for this population.
Finally, we showed that the FAST permits the detection of
differences not only between acute and remitted patients but also
between depressive and manic ones. This was evident in all areas
of functioning, except for the occupational functioning and
ﬁnancial issues. These preliminary ﬁndings suggest that the FAST
could be useful in clinical trials in detecting minimal changes
achieved by different treatments, including improvement and
worsening of symptoms (depressive episode, manic episode).
However, further larger longitudinal studies are required to vali-
date the present ﬁndings.
There are several limitations that should be considered when
interpreting the results of this study. First, the affected sample
was recruited from a tertiary hospital; participants in the study
are therefore likely to be weighted toward those with greater
illness severity and may not be readily generalizable to the wider
population of individuals living with BD. Second, we did not
control for the impact of mixed subthreshold symptoms on func-
tioning. Third, as we included hypomanic and manic patients in
the same group analysis, such differences in symptom severity
could represent a potential confounder. Fourth, this is a cross-
sectional study that does not allow us to determine the direction
of the relationship between mood symptoms and functional
impairment. Longitudinal studies are needed to understand the
cause-and-effect relationship between speciﬁc domains of func-
tioning and clinical factors.
Despite the above-mentioned limitations, our results suggest
that patients with depressive and manic episodes experience poor
psychosocial functioning in distinct areas and that these deﬁcits
persist in an attenuated form during periods of remission. The
results highlight the importance of treating both the symptoms of
mania and depression aggressively, and also suggest that when
patients are euthymic, treatment should focus on rehabilitative
measures to improve functioning. Therefore, the development of
psychosocial interventions aiming to improve functional out-
comes in patients with BD, and potentially their QoL, represents
an urgent challenge for future studies.
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